James R. Tobin
Lead Independent DirectorMr. James R. Tobin, also known as Jim, serves as a Director at Xenter, Inc. since February 8, 2021. He has been Independent Chairman at Transmedics Group, Inc. since 2011. He served as Director at Impulse Dynamics N.V. since November 2021. He serves as Member of Advisory Council at SVB Securities LLC. Mr. Tobin served as the Chief Executive Officer and President of Boston Scientific Corporation from March 1999 to July 13, 2009. Mr. Tobin served as the Chief Executive Officer and President of BSC International Corporation, a subsidiary of Boston Scientific Corp. since 1999. Mr. Tobin served as the Chief Executive Officer and President of Biogen Inc. (Biogen Idec, Inc.) from February 1997 to December 1998 and he served as its Chief Operating Officer from February 1994 to February 1997. He became President and Chief Operating Officer of Baxter in 1992. He was with Baxter International, rising from Financial Analyst to President and Chief Operating Officer. From 1972 to 1994, he served in a variety of executive positions with Baxter International Inc., a health care products company, where he served as President and Chief Operating Officer from 1992 to 1994, as Executive Vice President from 1988 to 1992 and in various management positions prior to 1988. He served at Baxter as Managing Director in Japan from 1975 to 1977, Managing Director in Spain from 1977 to 1980, President of Baxter's I.V. Systems Group from 1981 to 1986 and was promoted to Executive Vice President, responsible for worldwide business group, in 1988 and became responsible for Baxter's manufacturing and distribution business in 1990. He has been Chairman of the Board at Transmedics Group, Inc. (formerly known as TransMedics, Inc.) since July 2011. He is an Independent Director of Lyra Therapeutics, Inc. since March 4, 2022 and has been its Lead Independent Director since April 2022. He has been Director of Oxford Immunotec Limited since 2014. He had been Director of Corindus Vascular Robotics, Inc. since March 13, 2018 until October 29, 2019 and served as an Independent Non-Executive Director at Oxford Immunotec Global PLC since December 2, 2014 until March 08, 2021. He serves as a Director at Resolys Bio, Inc. He has been Independent Director of Globus Medical, Inc. since August 31, 2015. He serves as a Director of Celera Group, Beth Israel Deaconess Medical Center and Carl J. Shapiro Institute for Education and Research. He served as a Director of CardioDx, Inc. since April 2014 until March 9, 2017. He was Director at Aptus Endosystems, Inc. since October 2011 until 2015; He served as Independent Director of Chiasma, Inc. from November 30, 2015 to December 12, 2016. He served as a Director of Curis, Inc. from 1995 to November 9, 2015 and Medical Simulation Corp, from 2012 to 2018. He served as a Director of Osiris Therapeutics Inc. He served as a Director of Celera Corporation since 1999, Creative BioMolecules Inc. from January 1995 to July 2000, Boston Scientific Corporation from 1999 to July 13, 2009, Applied Biosystems Inc. since 1999, Applera Corp. since 1999 and PathoGenesis Corporation since January 1999. He is involved with the BioMedical Science Career Program. He served as Lieutenant in the US Navy from 1968 to 1972. Mr. Tobin holds an M.B.A. from Harvard Business School and a B.A. from Harvard College.
Positions
- Company NameLyra Therapeutics, Inc.Stock CodeLYRAPositionLead Independent DirectorColleagues
- CSCarmichael S. RobertsCo-Founder
- CAC. Ann MerrifieldIndependent Director
- VBVineeta BelangerSenior Vice President of Clinical Affairs
- ANAllison NanceSenior Vice President of Regulatory Affairs
- ERElazer R. EdelmanVP of Finance & Risk
- WBW. Bradford SmithIndependent Director
- JRJames R. TobinLead Independent Director
- NLNancy L. SnydermanIndependent Director
- Company NameTransMedics Group, Inc.Stock CodeTMDXPositionIndependent ChairmanColleagues
- WHWaleed H. HassaneinFounder, President, CEO & Director
- JRJames R. TobinIndependent Chairman
- NCNicholas CorcoranSenior Vice President of Supply Chain & Operations
- TITamer I. KhayalSenior Vice President of International
- FAFernando AraujoChief Financial Officer & Treasurer
- MFMatthew ForsythSenior VP, General Counsel & Corporate Secretary
- TJThomas J. GundersonIndependent Director
- EMEdward M. BasileIndependent Director
- MRMerilee RainesIndependent Director
- Company NameGlobus Medical, Inc.Stock CodeGMEDPositionIndependent DirectorColleagues
- DCDavid C. PaulCo-Founder & Executive Chairman
- KWKeith W. PfeilCEO, President & Director
- KRKyle R. KlinSenior VP & CFO
- KGKelly G. HullerExecutive VP, General Counsel & Corporate Secretary
- BJBrian J. KearnsSenior Vice President of Business Development & Investor Relations
- ADAnn D. RhoadsIndependent Director
- DDDavid D. DavidarIndependent Director
